What is CME Group's stock symbol?
CME Group trades on the NASDAQ under the ticker symbol "CME."
How often does CME Group pay dividends? What is the dividend yield for CME Group?
CME Group declared a quarterly dividend on Wednesday, February 8th. Stockholders of record on Friday, March 10th will be paid a dividend of $0.66 per share on Monday, March 27th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.15%. The ex-dividend date is Wednesday, March 8th. This is a positive change from CME Group's previous quarterly dividend of $0.60.
Where is CME Group's stock going? Where will CME Group's stock price be in 2017?
11 analysts have issued 1-year target prices for CME Group's shares. Their predictions range from $90.00 to $118.00. On average, they expect CME Group's stock price to reach $102.00 in the next twelve months.
When will CME Group announce their earnings?
CME Group is scheduled to release their next quarterly earnings announcement on Thursday, April, 27th 2017.
What are analysts saying about CME Group stock?
Here are some recent quotes from research analysts about CME Group stock:
According to Zacks Investment Research, "CME Group’s shares have modestly outperformed the Zacks categorized Securities Exchanges industry in a year’s time. Driven by higher revenues, the company’s fourth-quarter 2016 adjusted earnings per share beat the Zacks Consensus Estimate. The quarter witnessed solid growth in average daily volume (ADV) amid increased volatility driven by the U.S. presidential election and the December Fed rate hike. It remains well positioned for growth on the back of its strong market position with diverse derivative product lines. Efforts to expand and cross sell its core exchange-traded business through new product initiatives and global reach also support growth. Reaffirming its commitment to boost shareholders’ value, CME Group announced its annual variable dividend in Dec 2016. However, bottom-line growth remains limited by mounting expenses. The company projects higher expense in 2017." (2/8/2017)
J P Morgan Chase & Co analysts commented, "CME reported GAAP EPS of $0.95 and Adjusted EPS of $1.14. Revenue was a bit lower than expected on product RPC even though the mix generally improved for the quarter. Expenses were also lower, particularly comp. CME has a lot going on in product development and will invest more to bring a number of products to market. While we feel such investments are critical, we also feel that investors will only pay for them after-the-fact, rather than before. We continue to think of CME as a true income-growth investment idea and thus maintain the Overweight rating." (7/29/2016)
Who owns CME Group stock?
CME Group's stock is owned by a number of of retail and institutional investors. Top institutional investors include State Street Corp (5.32%), FMR LLC (2.14%), Edgewood Management LLC (1.69%), Janus Capital Management LLC (1.58%), Thornburg Investment Management Inc. (1.40%) and Investec Asset Management LTD (0.74%). Company insiders that own CME Group stock include Bryan T Durkin, Dennis Suskind, Derek Sammann, Hilda Harris Piell, James E Oliff, Jeffrey M Bernacchi, Jill A Harley, John W Pietrowicz, Julie Holzrichter, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Martin J Gepsman, Phupinder Gill, Robert Zagotta, Ronald A Pankau and Terrence A Duffy.
Who sold CME Group stock? Who is selling CME Group stock?
CME Group's stock was sold by a variety of institutional investors in the last quarter, including Alkeon Capital Management LLC, FIL Ltd, Credit Agricole S A, Dimensional Fund Advisors LP, Castleark Management LLC, Investec Asset Management LTD, First Republic Investment Management Inc. and Keybank National Association OH. Company insiders that have sold CME Group stock in the last year include Bryan T Durkin, Dennis Suskind, Derek Sammann, Hilda Harris Piell, James E Oliff, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Martin J Gepsman, Phupinder Gill, Ronald A Pankau and Terrence A Duffy.
Who bought CME Group stock? Who is buying CME Group stock?
CME Group's stock was bought by a variety of institutional investors in the last quarter, including DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, State Street Corp, Asset Management One Co. Ltd., Congress Asset Management Co. MA, Russell Investments Group Ltd., FMR LLC, Renaissance Technologies LLC and Elkfork Partners LLC.
How do I buy CME Group stock?
Shares of CME Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of CME Group stock cost?
One share of CME Group stock can currently be purchased for approximately $122.62.